MGM-15, MGM-16, 7-OH & What You Need to Know

The rules surrounding kratom-related alkaloids are changing, and we know many of our customers have questions about what comes next.

At Coastal Kratom, we believe in keeping our community informed. Whether you're following the latest news about 7-hydroxymitragynine (7-OH), MGM-15, MGM-16, or other kratom-derived compounds, we want you to have clear information without the rumors or unnecessary hype.

Here's what we know about the DEA's actions, what's already changed, and what we're continuing to watch.

What's Happening With Kratom Regulations in 2026?

On July 6, 2026, the Drug Enforcement Administration (DEA) published notices outlining plans to temporarily schedule certain kratom-related substances under the Controlled Substances Act.

The federal actions addressed several compounds, including:

• MGM-15: Also known as dihydro-7-hydroxymitragynine.

• MGM-16: A synthetic derivative related to 7-hydroxymitragynine.

• Mitragynine pseudoindoxyl (MGPI): Another potent kratom-related compound.

• 7-Hydroxymitragynine (7-OH): A naturally occurring kratom alkaloid that is also found in concentrated and enhanced formulations.

The distinction between these substances matters because the DEA has not approached every compound in exactly the same way.

You can follow official announcements through the DEA Diversion Control Division.

What Changed After the Initial 30-Day Notice?

When the original notices were published in July, there was uncertainty about when scheduling would take effect.

That timeline has since developed.

On August 26, 2026, the DEA temporarily placed MGM-15, MGM-16, and mitragynine pseudoindoxyl into Schedule I.

These federal controls are already in effect. The original August 6 date should therefore no longer be treated as a future deadline or an additional sales grace period.

On October 9, 2026, the DEA issued new Notices of Intent reflecting updated scientific recommendations. According to the FDA, existing temporary controls on MGM-15, MGM-16, and MGPI remain in effect during the new notice period.

For the latest details, visit the FDA's federal regulatory update on 7-OH and related compounds.

What About 7-Hydroxymitragynine (7-OH)?

The situation surrounding 7-OH is more nuanced.

Unlike MGM-15 and MGM-16, 7-OH occurs naturally in kratom leaves in small amounts. However, concentrated and enhanced 7-OH products have attracted significant attention from federal regulators.

In October 2026, federal health officials outlined a revised threshold-based approach intended to distinguish naturally occurring trace amounts from intentionally concentrated formulations.

The recommendations consider both the concentration of 7-OH or MGPI and the ratio of mitragynine to those substances.

These recommendations do not mean every kratom product containing trace amounts of 7-OH is automatically subject to the same federal controls.

At the same time, concentrated 7-OH products face serious regulatory and safety concerns. The FDA advises consumers to avoid these products and has stated that 7-OH cannot lawfully be added to conventional foods or marketed as a dietary supplement.

Read the FDA's consumer safety guidance on 7-OH products.

Does This Affect Traditional Kratom Products?

Not necessarily in the same way.

Federal regulators have distinguished traditional kratom leaf, which contains naturally occurring alkaloids, from products containing enhanced concentrations of certain compounds or synthetic derivatives.

However, that distinction does not mean all traditional kratom products are automatically lawful everywhere.

State laws, product formulations, labeling requirements, and other federal regulations can affect whether a particular product may be sold or shipped.

For customers, the important takeaway is simple: not all kratom products are regulated identically.

What Does This Mean for Coastal Kratom Customers?

We understand that changing regulations can be frustrating, especially when they affect products you've purchased before.

Our approach is to stay informed, review the regulations as they develop, and make responsible decisions about product availability.

As federal and state requirements change, certain products may be removed from our website, restricted from shipping to specific locations, or discontinued entirely.

We will continue reviewing affected products and updating our website as new information becomes available.

Product availability is always subject to applicable laws and regulatory requirements. We cannot guarantee continued availability or future restocks of affected items.

Where Can You Find Reliable Regulatory Updates?

There is plenty of speculation surrounding kratom legislation, but official sources are the best place to start.

We recommend following:

• DEA Diversion Control Division — Federal scheduling notices and enforcement updates.

• Federal Register — Official federal rules, notices, and regulatory documents.

• FDA 7-OH Information Center — Regulatory developments, research, and public health information.

• FDA Consumer Safety Guidance — Information about the potential risks associated with concentrated 7-OH products.

Frequently Asked Questions

Is MGM-15 banned in 2026?

MGM-15 was temporarily placed into Schedule I by the DEA on August 26, 2026. Federal Schedule I controls apply, including restrictions on manufacture, distribution, and possession except as legally authorized.

Is MGM-16 also a Schedule I substance?

Yes. MGM-16 was included in the August 26, 2026, temporary scheduling action alongside MGM-15 and mitragynine pseudoindoxyl.

Is 7-OH federally banned?

As of October 12, 2026, federal regulators have issued updated scheduling notices and recommendations addressing 7-OH above specified thresholds. The October notice itself should not be confused with a final scheduling order. Separate FDA restrictions and state laws may already apply to concentrated 7-OH products.

Is regular kratom leaf being scheduled?

The federal actions discussed here distinguish natural kratom leaf containing trace amounts of 7-OH from enhanced or concentrated products. That does not override existing state restrictions or other federal requirements.

Will Coastal Kratom continue carrying affected products?

We will evaluate products individually based on their ingredients, laboratory information, and applicable regulations. Products subject to legal restrictions will not remain available for unlawful sale or shipment.

Staying Informed, Together

The kratom industry continues to evolve, and 2026 has brought some significant regulatory developments.

We know that customers want straightforward answers, not speculation. That's why we'll continue following official announcements and sharing meaningful updates as the rules change.

Thanks for being part of the Coastal Kratom community. We appreciate your trust, and we'll keep doing our part to make reliable information easier to find.

Stay coastal. Stay informed.

Last updated: October 12, 2026.

Disclaimer: This article is provided for general educational purposes and is not legal or medical advice. Federal and state regulations may change. Always consult current government guidance and qualified professionals when evaluating product legality or safety.